Shenzhen Chipscreen Biosciences Hits Day Low Amid Price Pressure at CNY 26.92

Shenzhen Chipscreen Biosciences Co., Ltd. experienced a notable decline today, with its stock price dropping by 5.16% as it reached an intraday low of CNY 26.92. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 1.16% on the same day. Over the past week, Shenzhen Chipscreen has seen a decrease of 6.21%, while its performance over the last month shows a gain of 13.49%. However, the stock has faced challenges over the longer term, with a year-to-date decline of 6.98% and a significant drop of 20.06% over the past year. In comparison, the China Shanghai Composite has shown a positive return of 5.99% during the same period. Despite the recent downturn, the company has reported impressive growth metrics, including a remarkable increase in pre-tax profit and net profit for the most recent quarter. However, concerns remain regarding management efficiency, as indicated by a low return on capital employed and negative net worth. The stock's market capitalization stands at CNY 9,986 million, reflecting its large-cap status within the pharmaceuticals and biotechnology industry.